Study of Sildenafil for Treatment of SSRI-Antidepressant Sexual Dysfunction in Women
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This prospective double-blind, placebo-controlled (DBPC) study, assessed the efficacy of
sildenafil in women with serotonin reuptake inhibitor antidepressant-associated sexual
dysfunction (SRI-AASD) following the same protocol which previously established efficacy in
men with SRI-AASD.